|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2004-7-16
|
|
pubmed:abstractText |
The best way to deliver infusional 5-fluorouracil (5-FU) and folinic acid (FA) has yet to be determined. The aim of this prospective phase II trial was to verify the tolerability, activity and efficacy of chronomodulated 5-FU-FA (FF(5-16)) every 3 weeks in 48 untreated patients (group A), and 28 pretreated and four non-measurable, advanced colorectal cancer (ACC) patients (group B).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0171-5216
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
130
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
445-52
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:15205945-Adolescent,
pubmed-meshheading:15205945-Adult,
pubmed-meshheading:15205945-Aged,
pubmed-meshheading:15205945-Analysis of Variance,
pubmed-meshheading:15205945-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15205945-Child,
pubmed-meshheading:15205945-Child, Preschool,
pubmed-meshheading:15205945-Chronotherapy,
pubmed-meshheading:15205945-Colorectal Neoplasms,
pubmed-meshheading:15205945-Female,
pubmed-meshheading:15205945-Fluorouracil,
pubmed-meshheading:15205945-Humans,
pubmed-meshheading:15205945-Leucovorin,
pubmed-meshheading:15205945-Male,
pubmed-meshheading:15205945-Middle Aged,
pubmed-meshheading:15205945-Prospective Studies,
pubmed-meshheading:15205945-Quality of Life,
pubmed-meshheading:15205945-Questionnaires,
pubmed-meshheading:15205945-Survival Analysis,
pubmed-meshheading:15205945-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5-16) in advanced colorectal cancer patients.
|
|
pubmed:affiliation |
SC Oncologia Medica C, Istituto Regina Elena, Istituti Fisioterapici Ospitalieri, Via E. Chianesi, 53, 00144 Rome, Italy. garufi@ifo.it
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
